Literature DB >> 20150575

Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development.

L Audi1, M Fernández-Cancio, A Carrascosa, P Andaluz, N Torán, C Piró, E Vilaró, E Vicens-Calvet, M Gussinyé, M A Albisu, D Yeste, M Clemente, I Hernández de la Calle, M Del Campo, T Vendrell, A Blanco, J Martínez-Mora, M L Granada, I Salinas, J Forn, J Calaf, O Angerri, M J Martínez-Sopena, J Del Valle, E García, R Gracia-Bouthelier, P Lapunzina, E Mayayo, J I Labarta, G Lledó, J Sánchez Del Pozo, J Arroyo, A Pérez-Aytes, M Beneyto, A Segura, V Borrás, E Gabau, M Caimarí, A Rodríguez, M J Martínez-Aedo, M Carrera, L Castaño, M Andrade, J A Bermúdez de la Vega.   

Abstract

BACKGROUND: Androgen receptor (AR) gene mutations are the most frequent cause of 46,XY disorders of sex development (DSD) and are associated with a variety of phenotypes, ranging from phenotypic women [complete androgen insensitivity syndrome (CAIS)] to milder degrees of undervirilization (partial form or PAIS) or men with only infertility (mild form or MAIS).
OBJECTIVE: The aim of the study was to characterize the contribution of the AR gene to the molecular cause of 46,XY DSD in a series of Spanish patients.
SETTING: We studied a series of 133 index patients with 46,XY DSD in whom gonads were differentiated as testes, with phenotypes including varying degrees of undervirilization, and in whom the AR gene was the first candidate for a molecular analysis.
METHODS: The AR gene was sequenced (exons 1 to 8 with intronic flanking regions) in all patients and in family members of 61% of AR-mutated gene patients.
RESULTS: AR gene mutations were found in 59 individuals (44.4% of index patients), of whom 46 (78%) were CAIS and 13 (22%) PAIS. Fifty-seven different mutations were found: 21.0% located in exon 1, 15.8% in exons 2 and 3, 57.9% in exons 4-8, and 5.3% intronic. Twenty-three mutations (40.4%) had been previously described and 34 (59.6%) were novel.
CONCLUSIONS: AR gene mutation is the most frequent cause of 46,XY DSD, with a clearly higher frequency in the complete phenotype. Mutations spread along the whole coding sequence, including exon 1. This series shows that 60% of mutations detected during the period 2002-2009 were novel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150575     DOI: 10.1210/jc.2009-2146

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

1.  Emerging technologies in medical applications of minimum volume vitrification.

Authors:  Xiaohui Zhang; Paolo N Catalano; Umut Atakan Gurkan; Imran Khimji; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2011-08       Impact factor: 5.307

2.  Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.

Authors:  Christine Helsen; Vanessa Dubois; Annelien Verfaillie; Jacques Young; Mieke Trekels; Renée Vancraenenbroeck; Marc De Maeyer; Frank Claessens
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

3.  Is there any clinical relevant difference between non mosaic Klinefelter Syndrome patients with or without Androgen Receptor variations?

Authors:  Umberto Valente; Cinzia Vinanzi; Savina Dipresa; Riccardo Selice; Massimo Menegazzo; Massimo Iafrate; Carlo Foresta; Andrea Garolla
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

Review 4.  Effects of chromosomal sex and hormonal influences on shaping sex differences in brain and behavior: Lessons from cases of disorders of sex development.

Authors:  Matthew S Bramble; Allen Lipson; Neerja Vashist; Eric Vilain
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.

Authors:  Sarmistha Mukherjee; Osvaldo Cruz-Rodríguez; Eric Bolton; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

6.  Long-term biochemical evaluation of the androgen receptor pathway in males with disorders of sex development.

Authors:  C Schwentner; J Czyz; J Seibold; T Todenhoefer; S H Alloussi; H Klocker; G Gakis; A Stenzl; M Baka-Ostrowska; C Radmayr
Journal:  World J Urol       Date:  2010-12-15       Impact factor: 4.226

7.  Three novel and two known androgen receptor gene mutations associated with androgen insensitivity syndrome in sex-reversed XY female patients.

Authors:  Balachandran Saranya; Gunasekaran Bhavani; Brindha Arumugam; Meena Jayashankar; Sathiyavedu Thyagarajan Santhiya
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

8.  Different types of androgen receptor mutations in patients with complete androgen insensitivity syndrome.

Authors:  Jialiang Shao; Jiangang Hou; Bingkun Li; Dongyang Li; Ning Zhang; Xiang Wang
Journal:  Intractable Rare Dis Res       Date:  2015-02

9.  Malignant Germ Cell Tumors and Their Precursor Gonadal Lesions in Patients with XY-DSD: A Case Series and Review of the Literature.

Authors:  Sahra Steinmacher; Sara Y Brucker; Andrina Kölle; Bernhard Krämer; Dorit Schöller; Katharina Rall
Journal:  Int J Environ Res Public Health       Date:  2021-05-25       Impact factor: 3.390

10.  Minor hypospadias: the "tip of the iceberg" of the partial androgen insensitivity syndrome.

Authors:  Nicolas Kalfa; Pascal Philibert; Ralf Werner; Françoise Audran; Anu Bashamboo; Hélène Lehors; Myriam Haddad; Jean Michel Guys; Rachel Reynaud; Pierre Alessandrini; Kathy Wagner; Jean Yves Kurzenne; Florence Bastiani; Jean Bréaud; Jean Stéphane Valla; Gérard Morisson Lacombe; Mattea Orsini; Jean-Pierre Daures; Olaf Hiort; Françoise Paris; Kenneth McElreavey; Charles Sultan
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.